Page 10 - IMO-2-2
P. 10
Innovative Medicines & Omics Pharmacotherapy of obesity
will reach $3 trillion annually by 2030 and $18 trillion by hence leading to higher rates of obesity. This reflects the
2060. In addition, it is not merely a problem of high-income socioeconomic gradient in health whereby the poorest are
nations because the rates of obesity are also escalating in at risk of suffering from obesity-related diseases. 32
nations with low and middle incomes, making it a global While the dietary policy and environmental changes
health challenge. 26 have been very effective in preventing obesity within the
At the biological level, obesity is characterized by low- childhood population, combining these approaches with
degree systemic chronic inflammation backed by adipose education is lacking in most programs. Indeed, without
tissue. Acute-phase proteins like C-reactive protein are systemic comprehensive changes, simple educational
raised due to important inflammatory markers such as efforts are entirely too little to try to stem the growing tide
interleukin (IL)-1, IL-6, IL-8, and tumor necrosis factor of obesity. 33
alpha. Thus, an inflammatory milieu is established, Once thought to be comparatively a minor health
with both known and supposed ramifications. Long- issue, obesity has grown to become a major worldwide
27
term cardiovascular complications of obesity include priority in public health. Although the condition was first
an increased risk of atherosclerosis and heart disease, identified in 1948, it has long been perceived as a “personal
particularly when the condition begins in young lifestyle choice” that can be easily overcome with exercising
adulthood. The condition is associated with an increased through enhanced willpower. Observations from the last
mortality rate and tends to be chronic over time – these few decades have, however, shown that obesity is, in fact, a
risks are improved by weight loss. 28 multifaceted disease itself rather than an etiological cause
Furthermore, obesity depletes homeostasis, increasing for a large number of diseases. This type of postulation has
blood pressure, giving rise to kidney damage, fostering been gaining traction in the last ten years, especially when
endothelial dysfunction, oxidative stress, and liver diseases obesity began to morph from an invisible problem into
such as steatosis, increasing blood volume, and modifying one of medical significance for health systems around the
heart geometry. 29 world. 34
7. Obesity as a public health issue: During recent decades, obesity has turned into a
Socioeconomic consequences serious health problem both in developed and developing
countries. Since it puts a considerable burden on the
Healthcare expenditure may increase as a result of obesity’s healthcare system due to higher morbidity and mortality
comorbidities, such as asthma, sleep apnea, diabetes, from chronic, debilitating states associated with it,
and liver disease, due to their long-term treatment and the following should be accomplished. It affects every
increased demand for medical services. Indeed, with age group and all socioeconomic strata of population
the rising trend in diseases related to obesity, especially composition, but increasing rates of childhood obesity
in children, it portends a generation living shorter lives are of special concern since they pose long-term health
compared to their parents, emphasizing long-term public risks. 35
health implications. 30 Obese cases are becoming increasingly prevalent
It also hides a cost burden on the employers’ side. As throughout the world at every level of income. Although
the rate of obesity within the labor force is increasing, these vary by geographical region, sociodemographic,
the productivity losses arising due to health problems or behavioral, and genetic factors, all have contributed
absenteeism, or loss of efficiency at workplace add to an to its rise. Various biomarkers such as oxidative stress,
economic cost burden. The employers therefore should microRNA, and adipocytes have been unraveled for
realize the consequence of obesity on work performance predicting and diagnosing obesity, but a thorough
and offer the option of weight loss programs or health understanding of the condition is yet to be achieved. 36
intervention at the workplace that could offset some of the
economic costs. 31 8. Expenditure on obesity: A comparison of
costs in the United States and Europe
Income is a factor socially governing the rate of
obesity. It is expected that the richer someone is, the more Due to the high prevalence, obesity represents a global
value-added nutrients he has access to and the wider public health issue entailing considerable economic
opportunity he has for physical activities, which gives consequences both in Europe and the US. At an average
him/her added insurance for good health. Economic prevalence of 15.9%, US adults are affected by obesity at
constraints on practicing healthy eating and active lifestyle 36.5%, while those in Europe reach 15.9% accordingly.
plague members of lower-income groups more frequently, Regarding financial consequences, which are very
Volume 2 Issue 2 (2025) 4 doi: 10.36922/imo.8316

